Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA Officials propose for "US FDA - Telangana DCA Regulatory Forum" for future strategic collaboration

Ruchika Sharma3 Nov 2023 2:49 PM IST

This regulatory forum discusses elements of Observed Inspection for future participation of Inspectors of DCA, Telangana as an observer in the US FDA...

SPARC announces retirement of Dr Chitturi Trinadha Rao - Senior Vice President, Drug Discovery

Ruchika Sharma3 Nov 2023 1:30 PM IST

Mumbai: Sun Pharma Advanced Research Company Limited (SPARC) has announced that Dr Chitturi Trinadha Rao – Senior Vice President, Drug Discovery,...

Boehringer Ingelheim, AnGes sign manufacturing agreement for HGF gene therapy product

SPARC enters into an exclusive worldwide license agreement with Johns Hopkins University, IOCB for hair loss drug

Ruchika Sharma3 Nov 2023 12:30 PM IST

SCD-153 is a first-in-class topical drug for the treatment of alopecia areata developed jointly by SPARC, JHU and IOCB.

Lupin unveils Risperidone Long Acting Injectable in US

Lupin unveils Diazepam Rectal Gel in US

Ruchika Sharma3 Nov 2023 11:34 AM IST

Mumbai: Global pharma major Lupin Limited has announced the launch of Diazepam Rectal Gel, 10 mg and 20 mg, Rectal Delivery System, after its wholly...

Marksans Pharma Goa facility undergoes successful inspection from German Health Authorities

Ruchika Sharma2 Nov 2023 5:30 PM IST

Mumbai: Marksans Pharma Limited has recently announced that the Company's newly acquired Goa manufacturing facility has successfully undergone...

Lupin secures SBTi validation for emission reduction targets

Lupin secures tentative USFDA nod for Selexipag for Injection

Ruchika Sharma2 Nov 2023 4:30 PM IST

This product will be manufactured at Lupin's Nagpur facility in India.

Zydus, Guardant Health to co-promote Guardant360 portfolio of liquid, tissue biopsy tests across India, Nepal

Ruchika Sharma2 Nov 2023 3:30 PM IST

Guardant360 is a minimally invasive liquid biopsy test that provides comprehensive genomic profiling of all solid tumours by analysing circulating...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck bags USFDA nod for Keytruda plus gemcitabine, cisplatin to treat Biliary Tract Cancer

Ruchika Sharma2 Nov 2023 2:30 PM IST

KEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...

Natco Pharma net profit down 23.44 percent at Rs 517.9 crore in Q2

Natco Pharma Pharmacovigilance department successfully completes USFDA inspection

Ruchika Sharma2 Nov 2023 1:00 PM IST

Hyderabad: Natco Pharma Limited has announced the successful completion of United States Food and Drug Administration’s (USFDA) inspection of the...

Pfizer hair loss drug Litfulo approved in UK

Ruchika Sharma2 Nov 2023 11:30 AM IST

Alopecia areata is a condition where the immune system attacks hair follicles and causes hair to fall out, often in clumps.

Gilead's Kite, Epic Bio collaborate for development of new cancer therapies

Ruchika Sharma2 Nov 2023 10:00 AM IST

Under the terms of the agreement, Epic Bio will develop constructs for Kite-selected targets for use in CAR T-cell therapies directed to blood...

Zydus Lifesciences buys LiqMeds Group for around Rs 689 crore

Ruchika Sharma1 Nov 2023 4:45 PM IST

Zydus will pay an upfront consideration of GBP 68 million (around Rs 689 crore) and yearly earn-outs until 2026 depending on achievement of certain...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok